Table 2.
Characteristics comparison between CR and non-CR.
| Cases (n = 49) | Controls (n = 57) | P value | |
|---|---|---|---|
| Male gender, n (%) | 35 (71.43) | 46 (80.70) | 0.262 |
| Hypertension, n (%) | 36 (73.47) | 36 (63.16) | 0.257 |
| Diabetes mellitus, n (%) | 10 (20.41) | 13 (22.81) | 0.765 |
| Dyslipidemia, n (%) | 20 (40.82) | 26 (45.61) | 0.619 |
| Current smoking, n (%) | 19 (38.78) | 21 (36.84) | 0.838 |
| Alcohol abuse | 9 (18.37) | 10 (17.54) | 0.912 |
| Age, y | 65.20 ± 11.50 | 61.74 ± 11.11 | 0.120 |
| BMI, kg/m2, | 23.84 ± 2.86 | 24.05 ± 2.74 | 0.695 |
| Number of stents per patient | 1.55 ± 0.98 | 1.28 ± 0.77 | 0.116 |
| Left ventricular ejection fraction, % | 59.04 ± 10.07 | 61.75 ± 7.45 | 0.115 |
| Total cholesterol, mg/dL | 4.57 ± 1.24 | 4.80 ± 1.36 | 0.382 |
| Triglycerides, mg/dL | 1.70 ± 1.02 | 1.73 ± 1.30 | 0.907 |
| HDL cholesterol, mg/dL | 0.95 ± 0.23 | 0.98 ± 0.31 | 0.608 |
| LDL cholesterol, mg/dL | 2.81 ± 1.06 | 2.96 ± 0.99 | 0.459 |
| GLU, mmol/L | 6.12 ± 2.42 | 5.69 ± 1.75 | 0.284 |
| HbA1c, % | 6.23 ± 1.31 | 6.22 ± 1.42 | 0.972 |
| ALT, umol/L | 39.67 ± 32.75 | 38.95 ± 31.56 | 0.908 |
| AST, umol/L | 125.27 ± 183.75 | 126.30 ± 183.16 | 0.977 |
| TBIL, umol/L | 15.54 ± 9.21 | 14.35 ± 7.42 | 0.464 |
| Albumin (A), g/L | 37.73 ± 5.03 | 39.95 ± 5.02 | 0.026 |
| BUN, mmol/L | 5.83 ± 2.10 | 5.61 ± 2.30 | 0.618 |
| CREA, mmol/L | 72.53 ± 20.33 | 71.56 ± 20.06 | 0.807 |
| UA, umol/L | 342.71 ± 102.48 | 321.26 ± 84.86 | 0.241 |
| hsCRP, mg/L | 10.13 ± 17.91 | 12.00 ± 21.95 | 0.636 |
| PLT, ∗109/L | 191.22 ± 61.93 | 208.35 ± 85.68 | 0.248 |
| MPV, fL | 8.47 ± 1.40 | 8.03 ± 0.89 | 0.058 |
| PCT, % | 0.16 ± 0.04 | 0.17 ± 0.05 | 0.375 |
| PDW, % | 16.37 ± 0.63 | 16.32 ± 0.52 | 0.664 |
| P2Y12 CpG1, (%) | 43.31 ± 10.96 | 44.89 ± 9.26 | 0.420 |
| P2Y12 CpG2, (%) | 37.00 ± 7.52 | 37.32 ± 6.82 | 0.821 |